Secretory endometrium associated with breakthrough bleeding in estrogen-treated postmenopausal women.
Paradoxical secretory changes are described in benign endometria curetted for breakthrough bleeding in postmenopausal women on cyclic low dosage Premarin therapy. This purely histologic study, though favoring progesterone mediation, provides no definitive answer to the problem of pathogenesis. Future correlative morphologic and endocrine investigations are clearly indicated.
D004717:Endometrium / Q000473:pathology*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D014592:Uterine Hemorrhage / Q000473:pathology*
D004966:Estrogens, Conjugated (USP)